Promising Thrombin Biomarkers For Identifying High-Risk VTE Patients – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Geke C. Poolen et al, adding:
”Thrombin Generation and Thrombin Dynamics Are Associated with Recurrent Venous Thromboembolism After Anticoagulation Withdrawal
In 589 VTE patients, reduced endogenous thrombin potential, thrombomodulin sensitivity, and thrombin inactivation by antithrombin were significantly associated with VTE recurrence after stopping anticoagulation, highlighting these parameters as promising biomarkers for identifying high-risk patients.”
Title: Thrombin generation and thrombin dynamics are associated with recurrent venous thromboembolism after anticoagulation withdrawal
Authors: Geke C. Poolen, Romy M.W. de Laat-Kremers, Mark Roest, Geert-Jan Geersing, Rolf T. Urbanus, Bas de Laat, Roger E.G. Schutgens
Read the Full Article on JTH
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 25, 2026, 19:32Javier M. Floren: A Blood Clot Is One of the Most Impressive Examples of Teamwork You’ll Ever See
-
Jun 25, 2026, 19:31Marcin Krzysztof Maniak: Linking Tissue Mechanics to Inflammation in Health and Disease
-
Jun 25, 2026, 19:29Deepak Rawat: A Diagnosis Like Immune Thrombocytopenia Changes Your Perspective
-
Jun 25, 2026, 19:27Srikanth R.: Don’t Ignore Your Health While Chasing Success
-
Jun 25, 2026, 19:27Jamie Nash: Delighted to Receive the BBTS Race and Sanger Award 2026
-
Jun 25, 2026, 15:56Wolfgang Miesbach: Building the Future of Gene Therapy – From Centre Readiness to Long-Term Patient Care
-
Jun 25, 2026, 15:46Amber Yates: Making a Meaningful Difference for People Living with Sickle Cell Disease
-
Jun 25, 2026, 15:43Nancy Cavey: Navigating Disability Benefits for Patients with Immune Thrombocytopenia
-
Jun 25, 2026, 15:28Damon Race: Pursuing Long-Term Expression in Hemophilia A Gene Therapy